MediciNova (MNOV) has received a Notice of Allowance from the USPTO for a pending patent application for MN-001 – Tipelukast – to ...
The lawsuit, filed Tuesday in U.S. District Court in Delaware, is the latest in a series of patent challenges against ...
The European Medicines Agency has approved Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE) in children as young as one year of age. Specifically, the approval covers children aged one to ...
Approval based on Phase 3 data showing significantly more children aged 1 to 11 years on Dupixent achieved histological disease remission at 16 ...
The Unified Patent Court (UPC) is revolutionizing the way patents are enforced in Europe, and McDermott’s intellectual property (IP) team is here ...
Apple got a mixed victory in a patent infringement lawsuit against medical device maker Masimo. On Friday, a federal jury determined that Masimo had infringed on some Apple patents, and as part of ...
As usual, you can find the slides on sanofi.com. Please turn to Slide number ... I think we are very well-positioned for that ...
Sanofi (NASDAQ:SNY) shares gained on Friday after the French pharma giant exceeded analysts' estimates with its Q3 thanks mainly to earlier-than-anticipated vaccine sales and a 22% YoY rise in ...
Despite Merck & Co. homing in on approval for its infant respiratory syncytial virus (RSV) antibody clesrovimab, Sanofi—which last year won its own nod for its AstraZeneca-partnered RSV ...
Chief Minister A Revanth Reddy announced that a decision on pending DA will be made by Friday evening. On Thursday, the Employees Joint Action Committee, which includes both gazetted and non ...
Agomab Therapeutics is benefiting from Sanofi’s push to become an immunology powerhouse.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback